LGALS1 and skin basal cell carcinoma: However, variable levels of a product, which appeared to be 2–3 kDa larger than placental or recombinant hPL, were detected by the same antibodies in both BCC and choriocarcinoma cells, leading us to believe that it represent a post-translationally modified hPL (‘hPL’).